ATXN3 and Machado-Joseph disease: In summary, we show that early and permanent lentiviral-mediated expression of RNAi sequences (shRNAs) targeting mutant ataxin-3 can dramatically hamper the development of MJD-associated abnormalities, including behavioral and neuropathological deficits in a mouse model of MJD.